<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Cutaneous manifestations of sarcoidosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Cutaneous manifestations of sarcoidosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Cutaneous manifestations of sarcoidosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Steven Prystowsky, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Miguel Sanchez, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jeffrey Callen, MD, FACP, FAAD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Abena O Ofori, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 04, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H18191748"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Sarcoidosis is a granulomatous disease characterized by the presence of noncaseating granulomas in organs and tissue, such as the skin, lung, lymph nodes, eyes, joints, brain, kidneys, and heart. Cutaneous lesions may present with a variety of morphologies, including papules, nodules, plaques, and infiltrated scars  (<a class="graphic graphic_picture graphicRef73271 graphicRef53918 graphicRef59868 graphicRef52189 graphicRef69405 graphicRef78202 graphicRef51560 graphicRef62363 graphicRef74163 graphicRef70564" href="/d/graphic/73271.html" rel="external">picture 1A-J</a>).</p><p>The diagnosis of cutaneous sarcoidosis is supported by the recognition of compatible clinical features, the detection of classic histopathologic findings, and the exclusion of other granulomatous disorders. Compared with other sites of sarcoidal involvement, histopathologic sampling of lesions in the skin is a relatively simple and safe procedure. When present, cutaneous lesions can be a valuable asset in the confirmation of a diagnosis of sarcoidosis.</p><p>In addition to skin lesions that display noncaseating granulomas on biopsy, cutaneous eruptions that are not specific for sarcoidosis may also occur in patients with sarcoidosis. Erythema nodosum is the most frequent nonspecific cutaneous disorder associated with sarcoidosis.</p><p>The clinical manifestations and diagnosis of cutaneous sarcoidosis will be discussed here. The management of cutaneous sarcoidosis, the pathogenesis of sarcoidosis, and the manifestations of extracutaneous sarcoidosis are reviewed elsewhere.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/13773.html" rel="external">"Cutaneous sarcoidosis: Management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4365.html" rel="external">"Pathology and pathogenesis of sarcoidosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/91259.html" rel="external">"Overview of extrapulmonary manifestations of sarcoidosis"</a>.)</p><p></p><p class="headingAnchor" id="H3343640391"><span class="h1">CLASSIFICATION</span><span class="headingEndMark"> — </span>Skin manifestations of sarcoidosis are estimated to occur in approximately 25 percent of patients and are divided into specific and nonspecific lesions based on histopathologic features [<a href="#rid1">1-7</a>]. Patients may have both specific and nonspecific skin findings [<a href="#rid8">8</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Specific lesions</strong> – Specific skin lesions contain noncaseating (sarcoidal) granulomas, which represent the classic histopathologic findings in lesional tissue. Specific lesions are estimated to occur in 9 to as many as 36 percent of patients with sarcoidosis, depending upon the characteristics of the evaluated population and study design [<a href="#rid8">8,9</a>]. Although their histopathologic features are similar, the clinical manifestations of specific lesions vary widely. Papules, nodules, plaques, and infiltrated scars are among the most common presentations; other manifestations also occur [<a href="#rid9">9,10</a>]. (See <a class="local">'Specific lesions'</a> below and <a class="local">'Histopathology'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nonspecific lesions</strong> – All other cutaneous findings associated with sarcoidosis are classified as nonspecific. The nonspecific lesions of sarcoidosis include a wide spectrum of disorders.</p><p></p><p class="bulletIndent1">Erythema nodosum, which typically presents as inflammatory, tender nodules on the lower legs, is the most common nonspecific cutaneous lesion of sarcoidosis. In one study of 516 patients with sarcoidosis, erythema nodosum was present in 20 percent of all patients and in 62 percent of patients with cutaneous disease [<a href="#rid9">9</a>]. (See <a class="local">'Erythema nodosum'</a> below.)</p><p></p><p class="bulletIndent1">Other examples of nonspecific cutaneous manifestations include calcinosis cutis, Sweet syndrome, and nail clubbing [<a href="#rid7">7,11</a>]. (See <a class="local">'Nonspecific lesions'</a> below.)</p><p></p><p class="bulletIndent1">Although some authors have considered erythema multiforme a nonspecific manifestation of sarcoidosis [<a href="#rid12">12</a>], there is little evidence to support a definitive link between sarcoidosis and erythema multiforme.</p><p></p><p class="headingAnchor" id="H1437098698"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>The incidence and prevalence of sarcoidosis vary across populations [<a href="#rid13">13</a>]. Sarcoidosis is primarily a disease of adults but may also occur in children. General epidemiologic data for sarcoidosis are reviewed separately. (See  <a class="medical medical_review" href="/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis", section on 'Epidemiology'</a>.)</p><p>The epidemiology of cutaneous sarcoidosis has not been well studied. Although some studies suggest that sarcoidosis is more common in females and has a younger age of onset in males, data are insufficient for conclusions on age or sex predilection for cutaneous disease. In one retrospective study of 1429 patients with sarcoidosis in a pulmonary clinic in Sweden, female patients were more likely to have cutaneous involvement than male patients (13 versus 8 percent) [<a href="#rid14">14</a>]. Some data suggest that compared with adults, cutaneous involvement may be more common in children [<a href="#rid15">15</a>]. (See  <a class="medical medical_review" href="/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis", section on 'Epidemiology'</a>.)</p><p>Although racial variation in risk for sarcoidosis has been reported, the reasons and implications of these observations remain unclear. Such observations may be influenced by factors such as socioeconomic status, occupation, education, barriers to care, or other environmental and social factors [<a href="#rid13">13,16</a>]. Whether the prognosis of patients with cutaneous involvement differs among populations also remains to be determined. In a small retrospective study of patients in the United States in whom sarcoidosis was first diagnosed through cutaneous disease (n = 50), Black patients were more likely to have extracutaneous involvement and cardiac involvement compared with non-Black patients [<a href="#rid17">17</a>]. (See  <a class="medical medical_review" href="/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis", section on 'Epidemiology'</a>.)</p><p class="headingAnchor" id="H18191762"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>The factors that lead to the development of sarcoidosis are not well understood. The pathogenesis is thought to involve genetically influenced dysregulation of the T helper type 1 (Th1) immune response to one or more extrinsic antigens, an event that could lead to the overactivation of inflammatory pathways and subsequent granuloma formation [<a href="#rid18">18,19</a>].<strong> </strong>(See  <a class="medical medical_review" href="/d/html/4365.html" rel="external">"Pathology and pathogenesis of sarcoidosis"</a>.)</p><p>Multiple foreign bodies, infectious agents, and medications have been proposed as potential contributors to the development of sarcoidosis [<a href="#rid18">18,20-23</a>]. Polarizable material may be seen in 20 to 78 percent of skin biopsies of sarcoidosis, most commonly with papular, scar, and subcutaneous nodular types [<a href="#rid20">20,23,24</a>]. It is unknown whether environmental factors that come in contact with the skin serve as a nidus for granuloma formation or stimulate an aberrant immune response through other mechanisms [<a href="#rid18">18,19,25</a>]. Additional studies are necessary to explore the pathogenesis of cutaneous sarcoidosis.</p><p class="headingAnchor" id="H245206"><span class="h1">HISTOPATHOLOGY</span></p><p class="headingAnchor" id="H2980254447"><span class="h2">Findings</span><span class="headingEndMark"> — </span>The characteristic histopathologic finding in specific lesions of cutaneous sarcoidosis is the presence of sarcoidal noncaseating granulomas.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Noncaseating granulomas</strong> – Sarcoidal noncaseating granulomas consist of aggregates of epithelioid histiocytes, giant cells, and mature macrophages  (<a class="graphic graphic_picture graphicRef80383 graphicRef54204" href="/d/graphic/80383.html" rel="external">picture 2A-B</a>) [<a href="#rid26">26</a>]. These granulomas are surrounded by sparse lymphocytic infiltrates composed primarily of CD4<sup>+ </sup>T cell lymphocytes and a few CD8<sup>+</sup> lymphocytes. The absence of a dense lymphocytic infiltrate, such as is common in cutaneous lesions of tuberculosis, has led to the use of the term "naked granulomas" to describe this classic histopathologic finding in sarcoidosis.</p><p></p><p class="bulletIndent1">The giant cells located within sarcoidal granulomas may contain intracytoplasmic inclusions. These structures are found in other granulomas and are not pathognomonic of sarcoidosis [<a href="#rid4">4</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Asteroid bodies</strong> – Stellate, eosinophilic inclusions made up of complex lipids.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Schaumann (conchoidal) bodies</strong> – Round or oval inclusions consisting of laminated calcium oxalate; these may represent residual bodies of lysosomes.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Crystalline inclusions</strong> – Colorless, round or oval, refractile, nonlaminated inclusion bodies composed of calcium oxalate that may represent precursors of Schaumann bodies.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other potential findings</strong> – The histopathologic diagnosis of sarcoidosis is complicated by the fact that not all lesions of sarcoidosis demonstrate classic histopathologic findings [<a href="#rid4">4,23,26-32</a>]. While naked granulomas have been strongly associated with sarcoidosis, they are not always present. It is estimated that 71 to 89 percent of specific lesions of sarcoidosis contain typical sarcoidal granulomas [<a href="#rid4">4,23,33</a>]. Occasional cases of sarcoidosis may exhibit florid lymphocytic infiltrates at the periphery of granulomas, central caseation, vasculitis, or increased dermal mucin [<a href="#rid4">4,23,26-32</a>].</p><p></p><p class="bulletIndent1">Epidermal changes are present in some histopathologic specimens of sarcoidosis and are dependent upon lesion type. Atrophy and parakeratotic scale are the most common epidermal changes detected. Epidermal spongiosis, hyperplasia, and ulceration are present occasionally.</p><p></p><p class="bulletIndent1">Additional study is necessary to confirm whether certain histologic findings have clinical relevance. In a Spanish retrospective study of 41 patients with cutaneous sarcoidosis, the presence of a moderate or severe granulomatous infiltrate in biopsy specimens was associated with more severe clinical presentations of disease, more generalized disease, and a more chronic disease course [<a href="#rid34">34</a>].</p><p></p><p class="headingAnchor" id="H5641743"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>The differential diagnosis of specific lesions of cutaneous sarcoidosis includes a variety of other disorders that may exhibit granulomas on histopathologic examination.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infectious disorders</strong> – Deep fungal infections, mycobacterial infections, and other infections should be considered in the histopathologic differential diagnosis of cutaneous sarcoidosis. Microbial stains and fresh tissue cultures can assist with ruling out these diagnoses. Examples include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Tuberculosis (lupus vulgaris variant)</strong> – The histopathologic features of lupus vulgaris can closely resemble sarcoidosis. A granulomatous infiltrate located primarily in the upper dermis, a more prominent peripheral lymphocytic inflammatory infiltrate, and the presence of significant central necrosis in granulomas suggest a diagnosis of lupus vulgaris. Lesions of lupus vulgaris may also demonstrate ulceration, acanthosis, and pseudoepitheliomatous hyperplasia. A negative acid-fast stain does not rule out lupus vulgaris. (See  <a class="medical medical_review" href="/d/html/15866.html" rel="external">"Cutaneous manifestations of tuberculosis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Tuberculoid leprosy</strong> – Granulomas in tuberculoid leprosy are often elongated and located along the course of nerves. Unlike in sarcoidosis, central caseation is a common feature of granulomas in tuberculoid leprosy. Acid-fast stains reveal the presence of acid-fast bacilli in a minority of cases of tuberculoid leprosy. (See  <a class="medical medical_review" href="/d/html/5348.html" rel="external">"Leprosy: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1">Examples of other diseases in the differential diagnosis include infections due to nontuberculous mycobacteria (eg,<em> Mycobacterium marinum</em>, <em>M. kansasii</em>, <em>M. chelonae</em>, <em>M. fortuitum</em>, <em>M. ulcerans</em>, <em>M. abscessus</em>, <em>M. avium</em> complex, <em>M. xenopi</em>), brucellosis, tularemia, bartonellosis, aspergillosis, histoplasmosis, blastomycosis, coccidiomycosis, cryptococcosis, granulomatous herpes zoster, toxoplasmosis, leishmaniasis, echinococcosis, and enterobiasis [<a href="#rid35">35</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Noninfectious disorders</strong> – Foreign body reactions, drug reactions, and other noninfectious disorders are in the histopathologic differential diagnosis of cutaneous sarcoidosis.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Foreign body reactions</strong> – The identification of refractile material with polariscopic examination of a histopathologic specimen suggests a foreign body reaction. Giant cells with multiple nuclei in a haphazard arrangement (foreign-body giant cells) are often present.</p><p></p><p class="bulletIndent2">Examples of substances that may trigger granulomatous foreign body reactions include talc, starch, beryllium, titanium, nickel, aluminum, palladium mercury, silicone, zinc, oxalate, gel foam, biomaterials, cactus bristles, wood splinters, surgical sutures, pencil lead, artificial hair, insect mouthparts, cardiac pacing wires, and soft tissue fillers. (See  <a class="medical medical_review" href="/d/html/13652.html" rel="external">"Injectable soft tissue fillers: Permanent agents"</a> and  <a class="medical medical_review" href="/d/html/16399.html" rel="external">"Injectable soft tissue fillers: Temporary agents"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Drug-induced sarcoidosis-like reactions </strong>– Drug-induced sarcoidosis-like reactions are indistinguishable from sarcoidosis and occur in temporal relationship with initiation of a drug. (See <a class="local">'Drug-induced sarcoidosis-like reactions'</a> below.)</p><p></p><p class="bulletIndent1">Other possible causes of noninfectious cutaneous granulomas include sarcoid-like reaction to tumors, lymphoma, lymphomatoid granulomatosis, antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, rheumatoid nodules, Langerhans cell histiocytosis, immunoglobulin G4 (IgG4)-related disease, inflammatory bowel disease, orofacial granulomatosis, and Blau syndrome [<a href="#rid35">35</a>].</p><p></p><p class="headingAnchor" id="H245665"><span class="h1">ASSOCIATION WITH SYSTEMIC DISEASE</span><span class="headingEndMark"> — </span>Because there are no large, well-designed studies, the risk for the development of systemic involvement in patients who present with disease limited to the skin is unknown [<a href="#rid36">36,37</a>]. Systemic involvement is estimated to occur in 30 to 85 percent of patients with cutaneous sarcoidosis [<a href="#rid38">38</a>]. Cutaneous disease can be the initial sign of sarcoidosis; in a retrospective study of 18 patients with cutaneous sarcoidosis in Ireland, 12 patients (67 percent) had cutaneous lesions as the initial presentation of sarcoidosis [<a href="#rid39">39</a>].</p><p>Patients with the lupus pernio variant of cutaneous sarcoidosis or sarcoidosis manifesting in scars appear to have a high risk for pulmonary disease. In a retrospective study of 516 patients with sarcoidosis, pulmonary parenchymal involvement was present more frequently in patients with lupus pernio or sarcoidosis involving scar tissue (64 and 40 percent, respectively) than in patients with erythema nodosum or other specific lesions of sarcoidosis [<a href="#rid9">9</a>]. (See <a class="local">'Lupus pernio'</a> below.)</p><p>Isolated cutaneous disease might have a more favorable prognosis than the combination of cutaneous and systemic disease. In a Spanish retrospective study of 41 patients with cutaneous sarcoidosis who were followed for 3 months to 21 years (median 4 years), patients with isolated cutaneous involvement were less likely to have documentation of persistent disease activity for more than two years (29 versus 92 percent), and eventual complete resolution of skin lesions was more frequent in patients with isolated cutaneous disease (77 versus 33 percent) [<a href="#rid34">34</a>].</p><p class="headingAnchor" id="H18191778"><span class="h1">SPECIFIC LESIONS</span><span class="headingEndMark"> — </span>Specific eruptions of sarcoidosis are characterized by the presence of sarcoidal granulomas on histopathologic examination. Specific lesions may occur in a variety of morphologies but most commonly appear as papules or nodules. Lesions are often asymptomatic [<a href="#rid40">40</a>].</p><p>In children, the most common specific eruptions are papular, consisting of flat-topped papules, usually on the face. However, the entire spectrum of clinical cutaneous sarcoidosis has been described in children [<a href="#rid41">41,42</a>].</p><p class="headingAnchor" id="H463475983"><span class="h2">Impact of skin color</span><span class="headingEndMark"> — </span>The color of sarcoidosis skin lesions varies widely and may include shades of pink, red-brown, yellow-brown, purple-brown, or gray [<a href="#rid16">16</a>]. In individuals with highly pigmented skin, the erythema associated with cutaneous inflammation is often more subtle than in individuals with lightly pigmented skin.</p><p class="headingAnchor" id="H18191794"><span class="h2">Papular sarcoidosis</span><span class="headingEndMark"> — </span>Papular sarcoidosis is<strong> </strong>a common specific cutaneous manifestation of sarcoidosis  (<a class="graphic graphic_picture graphicRef78691 graphicRef69405" href="/d/graphic/78691.html" rel="external">picture 1E, 1K</a>) [<a href="#rid12">12</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – Papular sarcoidosis presents with numerous nonscaly, 1 to 10 mm papules. Lesions can be skin colored, yellow-brown, red-brown, violaceous, or hypopigmented. In some cases, the papules demonstrate a slight central depression [<a href="#rid12">12</a>]. Although papules can develop in chronic disease, this form of sarcoidosis is more common in patients with acute disease [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1">Papular sarcoidosis most frequently occurs on the face, with a predilection for the eyelids and nasolabial folds [<a href="#rid12">12</a>]. Coalescence of lesions may lead to the formation of annular or nonannular plaques [<a href="#rid43">43</a>]. Upon resolution, faintly discolored, occasionally atrophic macules may remain at previous sites of involvement [<a href="#rid44">44</a>].</p><p></p><p class="bulletIndent1">A rare, micropapular variant consists of small, 1 to 2 mm, flesh-colored to faintly erythematous, nonfollicular, variably pruritic papules that erupt on the trunk, extremities, and/or face [<a href="#rid45">45</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – Papular lesions of sarcoidosis may clinically resemble lichen planus, granuloma annulare, granulomatous rosacea, appendageal tumors, xanthelasma, or xanthomas [<a href="#rid7">7</a>]. Infrequently, lesions may resemble lichen nitidus  (<a class="graphic graphic_picture graphicRef73271" href="/d/graphic/73271.html" rel="external">picture 1A</a>) [<a href="#rid46">46,47</a>].</p><p></p><p class="headingAnchor" id="H4151068805"><span class="h2">Plaque sarcoidosis</span><span class="headingEndMark"> — </span>Plaque sarcoidosis is a common form of cutaneous sarcoidosis that presents with well-demarcated plaques [<a href="#rid16">16</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> –<strong> </strong>Plaque sarcoidosis often presents with oval or annular, indurated, discrete plaques that are skin colored, erythematous, or brown  (<a class="graphic graphic_picture graphicRef52189 graphicRef59868" href="/d/graphic/52189.html" rel="external">picture 1C-D</a>). Occasionally, scale is present. Frequent sites of involvement include the shoulders and arms, back, and buttocks [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent1">Less common variants of plaque sarcoidosis are reviewed below. (See <a class="local">'Angiolupoid sarcoidosis'</a> below and <a class="local">'Psoriasiform sarcoidosis'</a> below and <a class="local">'Verrucous sarcoidosis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – Examples of disorders that may clinically resemble plaque sarcoidosis include psoriasis, lichen planus, discoid lupus, granuloma annulare, cutaneous T cell lymphoma, lymphomatoid granulomatosis, Kaposi sarcoma, and secondary syphilis [<a href="#rid7">7</a>]. (See <a class="local">'Psoriasiform sarcoidosis'</a> below.)</p><p></p><p class="headingAnchor" id="H6092903"><span class="h2">Nodular sarcoidosis</span><span class="headingEndMark"> — </span>Nodular sarcoidosis is a relatively common form of cutaneous sarcoidosis that results from large collections of sarcoidal granulomas in the dermis or subcutaneous tissue [<a href="#rid9">9,10</a>]. In one series of patients with skin manifestations of sarcoidosis, nodules were present in 10 out of 28 patients (36 percent) [<a href="#rid10">10</a>]. (See <a class="local">'Subcutaneous sarcoidosis'</a> below.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – Nodules tend to be between 1 and 2 cm in diameter and may be single or multiple. On the nose, nodular sarcoidosis can resemble rosacea-associated rhinophyma  (<a class="graphic graphic_picture graphicRef50697" href="/d/graphic/50697.html" rel="external">picture 3</a>) [<a href="#rid48">48,49</a>]. (See  <a class="medical medical_review" href="/d/html/13621.html" rel="external">"Rosacea: Pathogenesis, clinical features, and diagnosis", section on 'Phenotypes'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The clinical differential diagnosis includes other types of nodular granulomas, such as foreign body reactions, granuloma annulare, rheumatoid nodules, lymphocytoma cutis, nodular cutaneous primary neoplastic and metastatic lesions, and atypical mycobacterial infections [<a href="#rid8">8</a>].</p><p></p><p class="headingAnchor" id="H29997403"><span class="h3">Subcutaneous sarcoidosis</span><span class="headingEndMark"> — </span>The terms "subcutaneous sarcoidosis" and "Darier-Roussy sarcoidosis" are used to describe nodular sarcoidosis that primarily involves the subcutaneous tissue  (<a class="graphic graphic_picture graphicRef78202" href="/d/graphic/78202.html" rel="external">picture 1F</a>) [<a href="#rid4">4</a>].</p><p>Estimates of the frequency of subcutaneous lesions in patients with sarcoidosis vary, ranging from 1 to 12 percent [<a href="#rid4">4,50-52</a>]. Based upon data from one retrospective review of 54 patients with subcutaneous sarcoidosis, the disorder may be more common in females and in middle-aged adults and may be associated with a predisposition to autoimmune disease [<a href="#rid53">53</a>]. Although some reports have suggested that subcutaneous sarcoidosis is a marker for an increased risk for systemic disease, the relationship remains controversial [<a href="#rid4">4,51,53,54</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – Subcutaneous sarcoidosis presents as erythematous, skin-colored, violaceous, or hyperpigmented nodules. On the forearms, lesions often follow a linear distribution and even coalesce to form bands [<a href="#rid53">53</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – Patients with sarcoidosis have an increased risk for the development of erythema nodosum, which can also present with erythematous, tender nodules. The possibility of erythema nodosum should be considered in patients with sarcoidosis who present with nodular lesions, particularly when the nodules are located on the lower legs. In contrast to erythema nodosum, nodules of subcutaneous sarcoidosis predominate on the upper extremities and are not usually or only mildly tender [<a href="#rid53">53</a>]. Biopsy is useful for distinguishing between these diagnoses [<a href="#rid53">53</a>]. (See <a class="local">'Erythema nodosum'</a> below.)</p><p></p><p class="bulletIndent1">Other lesions that may resemble subcutaneous sarcoidosis on clinical examination include lipomas, cysts, subcutaneous granuloma annulare, foreign body granulomas, or cutaneous manifestations of lymphoproliferative malignancies [<a href="#rid7">7</a>].</p><p></p><p class="headingAnchor" id="H18191808"><span class="h2">Lupus pernio</span><span class="headingEndMark"> — </span>Lupus pernio is a distinct form of cutaneous sarcoidosis. Lupus pernio disproportionally affects Black persons and females [<a href="#rid55">55</a>]. The presence of lupus pernio appears to be associated with an increased risk for extracutaneous disease, particularly sarcoidosis involving the respiratory tract [<a href="#rid4">4,6,56-58</a>]. Among 35 patients with lupus pernio in one case series, intrathoracic disease (lymphadenopathy or pulmonary abnormalities), upper respiratory disease, reticuloendothelial involvement, and ocular lesions were present in 74, 54, 54, and 37 percent, respectively [<a href="#rid55">55</a>]. When severe, granulomatous inflammation of the upper respiratory tract can result in airway obstruction [<a href="#rid58">58</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> –<strong> </strong>Lupus pernio is characterized by violaceous or erythematous, indurated, infiltrative plaques that are primarily distributed on the central face  (<a class="graphic graphic_picture graphicRef76184 graphicRef63312" href="/d/graphic/76184.html" rel="external">picture 4A-B</a>), usually the alar rim, nasal tip, and cheeks. Other frequent sites of involvement include the ears and lips. Less commonly, lesions may affect the dorsal hands, fingers, or toes. Of note, not all sarcoidosis lesions on the nose are lupus pernio [<a href="#rid58">58</a>].</p><p></p><p class="bulletIndent1">Lupus pernio is less responsive to treatment than other sarcoidosis lesions [<a href="#rid8">8</a>]. The skin lesions heal with scarring [<a href="#rid59">59</a>].</p><p></p><p class="bulletIndent1">Without treatment, the lesions progressively infiltrate and indurate, eventually resulting in erosion into the underlying cartilage and bone, causing considerable destruction and disfigurement [<a href="#rid40">40</a>]. Lytic and cystic bone lesions, especially in the hands and feet, can underly lesions of lupus pernio [<a href="#rid56">56</a>]. Among the 35 patients with lupus pernio in the case series described above, bone cysts were found in 50 percent of the patients who were radiographed, and in one-half of these cases, cysts were present in both the hands and feet [<a href="#rid55">55</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> –<strong> </strong>Examples of disorders that may resemble lupus pernio include cutaneous lupus erythematosus, lupus vulgaris, tuberculoid leprosy, and cutaneous benign or malignant lymphocytic infiltrates [<a href="#rid60">60,61</a>].</p><p></p><p class="headingAnchor" id="H797125"><span class="h2">Hypopigmented sarcoidosis</span><span class="headingEndMark"> — </span>Hypopigmented sarcoidosis is an uncommon clinical manifestation of sarcoidosis that is most prominent in individuals with highly pigmented skin [<a href="#rid16">16</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – Lesions manifest as hypopigmented, well-demarcated, round to oval macules, patches, or barely raised plaques  (<a class="graphic graphic_picture graphicRef74163 graphicRef63313" href="/d/graphic/74163.html" rel="external">picture 1I, 1L</a>) [<a href="#rid12">12,62</a>]. Skin-colored or erythematous papules can be found in the center of some lesions of hypopigmented sarcoidosis, leading to an appearance that resembles a fried egg.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – Examples of disorders with clinical findings that may resemble hypopigmented sarcoidosis include pityriasis lichenoides chronica, tinea versicolor, hypopigmented mycosis fungoides, leprosy, and vitiligo [<a href="#rid63">63</a>].</p><p></p><p class="headingAnchor" id="H18191815"><span class="h2">Atrophic and ulcerative sarcoidosis</span><span class="headingEndMark"> — </span>Atrophic sarcoidosis is a form of plaque sarcoidosis that presents with depressed, rather than elevated, plaques. Ulceration may accompany the clinical findings. The term "ulcerative-atrophic sarcoidosis" may be used to describe lesions that are both atrophic and ulcerated  (<a class="graphic graphic_picture graphicRef62363" href="/d/graphic/62363.html" rel="external">picture 1H</a>) [<a href="#rid64">64</a>].</p><p>Ulcerative-atrophic lesions occur in a minority of patients with sarcoidosis. In one retrospective series, ulcerative-atrophic sarcoidosis was detected in 7 out of 147 cases of cutaneous sarcoidosis (5 percent) [<a href="#rid65">65</a>]. All patients with ulcerative-atrophic lesions presented with other mucocutaneous manifestations of sarcoidosis, and the majority also had internal disease. Ulcerative sarcoidosis may be more common in female patients and Black patients than in other populations [<a href="#rid64">64,65</a>].</p><p>Lesions of atrophic sarcoidosis may share features with morphea. In addition, atrophic sarcoidosis can share clinical features with necrobiosis lipoidica or lipodermatosclerosis; these variants often ulcerate. Similar to other specific lesions of sarcoidosis, histopathologic examination of atrophic types of sarcoidosis reveals noncaseating granulomas.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Morpheaform </strong>–<strong> </strong>In the morpheaform variant, lesions begin as firm, sclerotic, flesh-colored or hyperpigmented plaques that evolve into depressed lesions over time [<a href="#rid7">7</a>]. The lesions occur more frequently on the lower extremities than on the upper extremities [<a href="#rid66">66</a>]. Histopathologic examination of the dermis reveals markedly thickened collagen bundles and obliteration of the subcutaneous tissue. Rarely, lesions occur in a linear distribution, a clinical presentation that closely resembles linear morphea [<a href="#rid67">67</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Necrobiosis lipoidica-like </strong>–<strong> </strong>In a rare subtype of atrophic sarcoidosis, the necrobiosis lipoidica variant, pink to violaceous plaques with depressed centers develop on the shins. Necrobiotic changes in collagen bundles surrounded by epithelioid histiocytes and foreign-body giant cells are present histologically.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lipodermatosclerosis-like </strong>–<strong> </strong>Lipodermatosclerosis-like atrophic sarcoidosis presents on the lower extremities as brown, indurated, circumferential, progressively fibrotic plaques. This variant of sarcoidosis should be considered in cases of lipodermatosclerosis (sclerosing panniculitis) that do not respond to compression and standard treatments. A feature that favors sarcoidosis is a unilateral distribution [<a href="#rid68">68</a>].</p><p></p><p class="headingAnchor" id="H630708"><span class="h2">Rare variants</span><span class="headingEndMark"> — </span>Angiolupoid, psoriasiform, and verrucous sarcoidosis are rare variants of plaque sarcoidosis. Ichthyosiform and erythrodermic sarcoidosis are additional uncommon variants that present with extensive cutaneous involvement [<a href="#rid40">40</a>].</p><p class="headingAnchor" id="H18191822"><span class="h3">Angiolupoid sarcoidosis</span><span class="headingEndMark"> — </span>Angiolupoid sarcoidosis (also called Brocq-Pautrier angiolupoid) is a variant of plaque sarcoidosis characterized by the presence of prominent, large telangiectasias. Usually a single minimally raised plaque develops on the central face, ears, or scalp; females are most frequently affected  (<a class="graphic graphic_picture graphicRef71687 graphicRef70564" href="/d/graphic/71687.html" rel="external">picture 1J, 1M</a>) [<a href="#rid69">69</a>]. The center of the lesion may be relatively lighter in color than the periphery, and in some cases, the plaque may possess an annular configuration. Angiolupoid sarcoidosis may be mistaken for rosacea or a large basal cell carcinoma.</p><p class="headingAnchor" id="H18191829"><span class="h3">Psoriasiform sarcoidosis</span><span class="headingEndMark"> — </span>Psoriasiform sarcoidosis is a type of plaque sarcoidosis that presents with well-demarcated, erythematous, scaly plaques that may be indistinguishable from psoriasis  (<a class="graphic graphic_picture graphicRef50608" href="/d/graphic/50608.html" rel="external">picture 5</a>). In contrast to psoriatic lesions, sarcoidal plaques may resolve with scarring or atrophy.</p><p>Despite sharing a T helper type 1 (Th1) and T helper type 17 (Th17) pathogenesis, the association of psoriasis with sarcoidosis is rare, with the largest reported series consisting of seven cases. The authors suggested that uveitis may be less common in these patients, but the series is too small for conclusions [<a href="#rid70">70</a>].</p><p class="headingAnchor" id="H18191850"><span class="h3">Verrucous sarcoidosis</span><span class="headingEndMark"> — </span>Lesions of verrucous sarcoidosis consist of well-demarcated, exophytic, hyperkeratotic plaques or discrete, papillomatous, skin-colored papules  (<a class="graphic graphic_picture graphicRef62566" href="/d/graphic/62566.html" rel="external">picture 6</a>) or plaques [<a href="#rid71">71</a>]. Most cases involve the lower extremities. Lesions may resemble warts, prurigo nodularis, or hypertrophic lichen planus [<a href="#rid71">71</a>]. Patients usually have systemic involvement, frequently manifesting as significant pulmonary disease [<a href="#rid72">72</a>].</p><p class="headingAnchor" id="H950360519"><span class="h3">Disseminated lichenoid sarcoidosis</span><span class="headingEndMark"> — </span>Disseminated lichenoid sarcoidosis is a very rare type characterized by multiple discrete, miliary and lichenoid papules over patches of erythema in a distribution that may be so widespread as to resemble erythroderma [<a href="#rid73">73</a>].</p><p class="headingAnchor" id="H18191864"><span class="h3">Ichthyosiform sarcoidosis</span><span class="headingEndMark"> — </span>The findings of ichthyosiform sarcoidosis consist of adherent, irregular, polygonal, dry, gray or brown scales varying in size from 0.1 to 1 cm. The most common sites of involvement are the lower extremities, especially the pretibial area  (<a class="graphic graphic_picture graphicRef53092" href="/d/graphic/53092.html" rel="external">picture 7</a>) [<a href="#rid74">74</a>].</p><p>The skin lesions usually appear concurrently with or precede the diagnosis of systemic sarcoidosis but may also occur in the setting of established systemic disease [<a href="#rid75">75</a>]. It is estimated that 95 percent of patients eventually develop systemic involvement [<a href="#rid56">56</a>]. In a literature review that identified reports of 34 patients with ichthyosiform sarcoidosis, 31 patients (91 percent) had extracutaneous involvement, with the most common sites being the lungs (66 percent), lymph nodes (57 percent), and eyes (31 percent) [<a href="#rid74">74</a>].</p><p>The patient's history and the detection of dermal noncaseating granulomas in a biopsy specimen from affected tissue distinguish sarcoidal ichthyosis from other forms of ichthyosis [<a href="#rid76">76</a>]. Rarely, sarcoidosis manifests as ichthyosiform erythroderma, with sudden development of diffuse erythema and ichthyotic scale [<a href="#rid77">77</a>]. (See <a class="local">'Erythrodermic sarcoidosis'</a> below.)</p><p>The detection of a diminished stratum corneum and hyperkeratosis, in addition to sarcoidal granulomas, helps to establish the diagnosis of this variant. In the literature review that included 34 patients with ichthyosiform sarcoidosis, a diminished stratum corneum and hyperkeratosis were identified in 63 and 51 percent of patients, respectively [<a href="#rid74">74</a>].</p><p class="headingAnchor" id="H18191871"><span class="h3">Erythrodermic sarcoidosis</span><span class="headingEndMark"> — </span>Erythrodermic sarcoidosis typically begins with slightly infiltrated, erythematous to yellow-brown plaques that subsequently coalesce over large areas of the skin  (<a class="graphic graphic_picture graphicRef51460 graphicRef63230" href="/d/graphic/51460.html" rel="external">picture 8A-B</a>) [<a href="#rid78">78-81</a>]. Desquamation is common. In contrast to classic exfoliative erythroderma, some areas of skin are usually spared. Patients with erythrodermic sarcoidosis may have symptoms or signs of concomitant systemic involvement, such as fever, weight loss, arthralgias, uveitis, and dyspnea [<a href="#rid79">79</a>].</p><p>The absence of large, thick, polygonal scales differentiates erythrodermic sarcoidosis from nonsarcoidal ichthyosiform erythroderma. The course of the disease is variable. Histopathologic evaluation is necessary to exclude more common causes of erythroderma, such as psoriasis, eczema, drug eruptions, and cutaneous T cell lymphoma [<a href="#rid82">82</a>].</p><p class="headingAnchor" id="H950360540"><span class="h3">Perforating sarcoidosis</span><span class="headingEndMark"> — </span>The typical cutaneous manifestations of perforating sarcoidosis are papules with keratotic plug [<a href="#rid83">83</a>]. However, transepithelial elimination, a characteristic histopathologic finding of perforating disorders, has been reported in other types of lesions, such as facial papules. In one report, the presence of transepithelial elimination in scaly, pruritic, pubic papules and atrophic, vulvar patches resembling lichen sclerosus prompted the authors to examine previous biopsies of cutaneous sarcoidosis cases [<a href="#rid84">84</a>]. They found that transepithelial elimination, defined as "epithelial channel formation with a sarcoidal-type granuloma completely surrounded by squamous epithelium," was present in<strong> </strong>9 of 50 (18 percent) of their skin sarcoidosis cases.</p><p class="headingAnchor" id="H2494761"><span class="h3">Other</span><span class="headingEndMark"> — </span>Other rare forms of cutaneous sarcoidosis reported in the literature include pustular sarcoidosis and a photodistributed form of sarcoidosis [<a href="#rid12">12,85-87</a>]. It is unclear whether photodistributed sarcoidosis is a true entity or whether lesions actually represent the granulomatous variant of rosacea.</p><p>In addition, it remains to be seen whether syringotropic sarcoidosis, cutaneous sarcoidosis histologically characterized by granulomas surrounding eccrine glands, is a distinct clinical variant. Syringotropic sarcoidosis was reported in three female patients who presented with erythematous patches and plaques on the lower extremities (resembling asteatotic eczema) and localized hypohidrosis [<a href="#rid88">88</a>]. Anhidrosis may also occur as a feature of systemic sarcoidosis due to sarcoidosis-associated autonomic dysfunction [<a href="#rid89">89</a>].</p><p class="headingAnchor" id="H244886"><span class="h2">Special sites</span><span class="headingEndMark"> — </span>Several presentations of specific lesions of sarcoidosis have been described based upon the sites of lesion development. Examples include scar, tattoo, hair/scalp, nail, genital, and oral areas.</p><p class="headingAnchor" id="H797331"><span class="h3">Scar sarcoidosis</span><span class="headingEndMark"> — </span>The presence of sarcoidal granulomas in scar tissue is a relatively common manifestation of cutaneous sarcoidosis [<a href="#rid9">9</a>]. In one series of 170 patients with cutaneous sarcoidosis, 15 patients (9 percent) presented with disease involving scars [<a href="#rid9">9</a>].</p><p>Scars from surgical incisions, venipuncture, acne, pseudofolliculitis barbae, herpes zoster virus, and other forms of skin trauma are potential sites for the development of lesions [<a href="#rid90">90-92</a>]. Affected scars thicken and occasionally become erythematous or violaceous. Lesions are often asymptomatic, but some patients may note a sensation of irritation.</p><p>Scar sarcoidosis can occur as early as six months to as long as 59 years after an injury [<a href="#rid93">93</a>]. Scar sarcoidosis can also appear acutely in patients with Löfgren syndrome. (See  <a class="medical medical_review" href="/d/html/5583.html" rel="external">"Sarcoid arthropathy"</a>.)</p><p>Scar sarcoidosis may be more common than recognized since some lesions may be misdiagnosed as hypertrophic scars or keloids. Like sarcoidosis, keloids respond to intralesional corticosteroid therapy.</p><p>Koebnerization (the appearance of skin disease at sites of skin injury) may be a factor in some cases of scar or tattoo sarcoidosis. The development of erythematous sarcoidosis papules along veins on sites previously injected with narcotics has been reported [<a href="#rid94">94</a>].</p><p>The relationship between scar sarcoidosis and systemic sarcoidosis remains unclear. While some authors have proposed a strong link between scar sarcoidosis and systemic disease [<a href="#rid95">95,96</a>], others have commented on a more benign nature and good prognosis in patients who present with isolated scar sarcoidosis [<a href="#rid7">7,97</a>].</p><p class="headingAnchor" id="H797338"><span class="h3">Tattoo sarcoidosis</span><span class="headingEndMark"> — </span>Sarcoidal granulomas can develop in tattoos and may be the initial presentation of sarcoidosis in some patients. Tattoo sarcoidosis can occur within one year of tattoo placement or may develop decades after the tattoo was obtained [<a href="#rid98">98</a>]. Although red ink (cinnabar) tattoos are most commonly affected, sarcoidal infiltration in tattoos created with other pigments can also occur. The development of sarcoidal granulomas in tattoos of the eyebrows and lips has also been reported [<a href="#rid98">98</a>].</p><p>Affected tattoos develop papules within them or become raised, firm, and edematous  (<a class="graphic graphic_picture graphicRef51560" href="/d/graphic/51560.html" rel="external">picture 1G</a>). Patients may experience pain or pruritus at sites of involvement.</p><p>Histopathologic examination reveals the presence of sarcoidal granulomas showing aggregates of epithelioid cells surrounded by peripheral rings of lymphocytes [<a href="#rid98">98</a>]. The histopathologic differential diagnosis includes foreign body reactions to tattoo pigment, which also present with granulomatous infiltrates in the dermis.</p><p>Since sarcoidal tattoo reactions can be the presenting signs of sarcoidosis, patients who present with these lesions should be evaluated for systemic disease. In one retrospective case series of 19 patients with scar sarcoidosis, hilar adenopathy, uveitis, arthritis, or pulmonary disease were present in 74, 21, 16, and 16 percent, respectively [<a href="#rid98">98</a>].</p><p class="headingAnchor" id="H18191906"><span class="h3">Alopecia</span><span class="headingEndMark"> — </span>Hair loss is an uncommon specific manifestation of sarcoidosis. Sarcoidal alopecia is primarily seen on the scalp but may be seen in other areas, such as the face [<a href="#rid99">99</a>]. Alopecia may be scarring or nonscarring.</p><p class="headingAnchor" id="H796718920"><span class="h3">Scalp sarcoidosis</span><span class="headingEndMark"> — </span>Lesions on the scalp typically present as localized atrophic, annular, or indurated plaques or skin-colored or erythematous nodules  (<a class="graphic graphic_picture graphicRef57221" href="/d/graphic/57221.html" rel="external">picture 9</a>). Associated hair loss depends on the degree of sarcoidal involvement of the hair follicles and is not always present. Scale is usually absent but may be seen in some cases [<a href="#rid100">100,101</a>]. If scalp disease progresses, local destruction and scarring of hair follicles leads to the development of permanent alopecia that is indistinguishable from pseudopelade of Brocq. In some cases, scalp involvement may become extensive, leading to significant hair loss [<a href="#rid100">100</a>].</p><p>Follicular plugging, as seen in discoid lupus erythematosus, may also be present in patients with alopecia secondary to sarcoidosis [<a href="#rid102">102</a>]. The presence of orange spots on trichoscopy has been reported as a possible diagnostic clue for sarcoidosis [<a href="#rid103">103</a>].</p><p class="headingAnchor" id="H18191913"><span class="h3">Nail sarcoidosis</span><span class="headingEndMark"> — </span>Sarcoidosis involving the fingers or toes can produce a wide variety of nail plate changes [<a href="#rid104">104</a>], such as thinning, brittleness, pitting, thickening, transverse layering (nail splitting), increased convexity, onycholysis [<a href="#rid105">105</a>], subungual hyperkeratosis [<a href="#rid106">106</a>], clubbing, pseudoclubbing, paronychia with nail fold fissuring, pterygium [<a href="#rid107">107</a>], longitudinal ridging [<a href="#rid108">108</a>], splinter hemorrhages [<a href="#rid109">109</a>], and red or brown discoloration of the nail bed [<a href="#rid110">110,111</a>]. Disease progression can eventually result in pterygium formation (adherence of the proximal nail fold to the nail bed) and total loss of the nail (anonychia).</p><p>Granulomatous infiltration of the nail matrix and compression by sarcoidal granulomas on nail structures may contribute to the appearance of nail dystrophy. Sarcoidal nail plate dystrophy is often accompanied by phalangeal bone disease.</p><p>The combination of nail disease and bone involvement can occur in sarcoidal dactylitis, a variant of sarcoidosis that presents with bilateral fusiform or sausage-shaped swellings of the fingers  (<a class="graphic graphic_picture graphicRef64864" href="/d/graphic/64864.html" rel="external">picture 10</a>) [<a href="#rid52">52</a>]. Radiographic examination of affected digits reveals erosions in the distal phalanges. "Drumstick dactylitis," a rare severe form of sarcoidal dactylitis characterized by bulbous swelling of the fingertips, has been associated with lupus pernio [<a href="#rid54">54</a>]. (See <a class="local">'Lupus pernio'</a> above.)</p><p class="headingAnchor" id="H244631"><span class="h3">Genital sarcoidosis</span><span class="headingEndMark"> — </span>There have been only a few reports of vulvar sarcoidosis, which can present with papules, plaques, or nodules [<a href="#rid112">112-114</a>]. Sarcoidosis of the male genitalia may present as indurated papules, painful nodules with or without ulceration, or swelling of the scrotum or penis [<a href="#rid115">115-119</a>].</p><p class="headingAnchor" id="H244638"><span class="h3">Sarcoidosis of the oral cavity</span><span class="headingEndMark"> — </span>Sarcoidosis involving the oral cavity is rare, with less than 70 reported cases. Presentations include papules; papulonodules; edema; ulcers; or gingival abnormalities, such as gingivitis, gingival hyperplasia, or gingival recession  (<a class="graphic graphic_picture graphicRef67531" href="/d/graphic/67531.html" rel="external">picture 11</a>) [<a href="#rid120">120-123</a>]. In a review of 47 cases of sarcoidal involvement of the soft tissues of the oral cavity, nodules and localized swelling were the most frequent manifestations of mucosal disease, occurring in 34 patients (72 percent) [<a href="#rid120">120</a>]. In the soft tissues of the oral cavity, the most commonly affected site was the buccal mucosa (28 percent), followed by the gingiva (22 percent), lips (13 percent), floor of the mouth or sublingual glands (11 percent), tongue (11 percent), palate (6 percent), and submandibular gland (4 percent) [<a href="#rid120">120</a>].</p><p class="headingAnchor" id="H18191920"><span class="h1">NONSPECIFIC LESIONS</span><span class="headingEndMark"> — </span>Erythema nodosum is the most common nonspecific cutaneous manifestation of sarcoidosis.</p><p class="headingAnchor" id="H18191929"><span class="h2">Erythema nodosum</span><span class="headingEndMark"> — </span>Erythema nodosum develops in up to 25 percent of patients with sarcoidosis and is clinically and histologically identical to erythema nodosum secondary to other causes [<a href="#rid11">11</a>]. Sarcoidosis is a relatively common cause of erythema nodosum; in a Spanish study of 106 biopsy-proven cases of erythema nodosum, 20 percent of patients had sarcoidosis [<a href="#rid124">124</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – Patients with erythema nodosum develop erythematous, tender, subcutaneous plaques and nodules predominantly located on the anterior tibial areas  (<a class="graphic graphic_picture graphicRef76621 graphicRef55744" href="/d/graphic/76621.html" rel="external">picture 12A-B</a>) [<a href="#rid43">43</a>]. Arthritis, lower extremity edema, and low-grade fever are the most common systemic symptoms associated with erythema nodosum. (See  <a class="medical medical_review" href="/d/html/5612.html" rel="external">"Erythema nodosum"</a>.)</p><p></p><p class="bulletIndent1">Erythema nodosum is a transient disorder. In a case series that included 251 patients with sarcoidosis-associated erythema nodosum, over 85 percent had complete resolution within two years [<a href="#rid125">125</a>]. In addition, erythema nodosum has been associated with a favorable prognosis for sarcoidosis [<a href="#rid125">125,126</a>].</p><p></p><p class="bulletIndent1">Löfgren syndrome is an acute presentation of sarcoidosis characterized by the triad of hilar adenopathy, erythema nodosum, and polyarthralgia or arthritis, with or without parenchymal infiltrates or fever [<a href="#rid127">127-129</a>]. (See  <a class="medical medical_review" href="/d/html/5583.html" rel="external">"Sarcoid arthropathy", section on 'Acute arthritis and Lofgren syndrome'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The clinical features of subcutaneous sarcoidosis can resemble erythema nodosum [<a href="#rid130">130</a>]. Biopsy is useful for distinguishing between these disorders. Histopathologic findings in erythema nodosum are consistent with a septal panniculitis. Additional disorders in the differential diagnosis of erythema nodosum are reviewed separately. (See  <a class="medical medical_review" href="/d/html/5612.html" rel="external">"Erythema nodosum", section on 'Differential diagnosis'</a>.)</p><p></p><p class="bulletIndent1">The presence of bilateral hilar adenopathy and erythema nodosum is usually, but not always, caused by acute sarcoidosis. This presentation has also been reported in tuberculosis, lymphoma, streptococcal infection, histoplasmosis, coccidiomycosis, and <em>Chlamydia pneumoniae</em> infection [<a href="#rid131">131,132</a>]. (See  <a class="medical medical_review" href="/d/html/5612.html" rel="external">"Erythema nodosum"</a>.)</p><p></p><p class="headingAnchor" id="H4176051524"><span class="h2">Other disorders</span><span class="headingEndMark"> — </span>Examples of other nonspecific eruptions include calcinosis cutis, erythema multiforme, prurigo, Sweet syndrome, and nail clubbing.</p><p class="headingAnchor" id="H2216999117"><span class="h1">DRUG-INDUCED SARCOIDOSIS-LIKE REACTIONS</span><span class="headingEndMark"> — </span>Drug-induced sarcoidosis-like reactions (DISR) are clinically and histopathologically indistinguishable from sarcoidosis and occur in temporal relationship with initiation of a drug [<a href="#rid133">133</a>]. Similar to sarcoidosis, DISR can affect various organ systems and can include the development of sarcoid-like, granulomatous skin lesions. Multiple drugs have been associated with DISR. Tumor necrosis factor (TNF)-alpha antagonists (<a class="drug drug_general" data-topicid="8583" href="/d/drug information/8583.html" rel="external">adalimumab</a>, <a class="drug drug_general" data-topicid="8925" href="/d/drug information/8925.html" rel="external">etanercept</a>, <a class="drug drug_general" data-topicid="8984" href="/d/drug information/8984.html" rel="external">infliximab</a>), interferons, and immune checkpoint inhibitors (<a class="drug drug_general" data-topicid="16084" href="/d/drug information/16084.html" rel="external">ipilimumab</a>, <a class="drug drug_general" data-topicid="98764" href="/d/drug information/98764.html" rel="external">nivolumab</a>, <a class="drug drug_general" data-topicid="96957" href="/d/drug information/96957.html" rel="external">pembrolizumab</a>, unspecified anti-programmed death ligand 1 [PD-L1] antibody) are among the most commonly reported contributors [<a href="#rid134">134</a>]. (See  <a class="medical medical_review" href="/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis", section on 'Differential diagnosis'</a>.)</p><p class="headingAnchor" id="H18191964"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H1651630946"><span class="h2">Approach</span><span class="headingEndMark"> — </span>The diagnosis of sarcoidosis requires a compatible clinical picture, the demonstration of noncaseating granulomas on tissue biopsy, and the exclusion of other disorders that can present with similar clinical and histopathologic findings [<a href="#rid35">35,135</a>].</p><p>Accordingly, a diagnosis of <strong>cutaneous</strong> sarcoidosis is supported by these findings:</p><p class="bulletIndent1"><span class="glyph">●</span>The identification of skin lesions that are morphologically compatible with sarcoidosis</p><p class="bulletIndent1"><span class="glyph">●</span>The detection of sarcoidal granulomas on histopathologic examination</p><p class="bulletIndent1"><span class="glyph">●</span>The exclusion of other disorders in the differential diagnosis</p><p></p><p>The initial diagnostic work-up includes a physical examination and skin biopsy. In some cases, sarcoidosis may be suspected based upon the physical examination; however, given the wide variety of clinical presentations of sarcoidosis, the diagnosis is not always suspected prior to the results of histopathologic examination.</p><p>When physical examination and biopsy findings consistent with sarcoidosis are identified in a patient without a known history of the disease, an assessment for signs of extracutaneous sarcoidosis is indicated. This typically includes a review of systems, complete physical examination, chest radiography, and additional tests. Given the accessibility of the skin and ease of skin biopsy, recognition of lesions of cutaneous sarcoidosis can be highly valuable in patients with symptoms or radiologic findings that are suggestive of systemic disease, as they may prevent the need for a more invasive tissue biopsy in some patients. (See <a class="local">'Evaluation for systemic disease'</a> below and  <a class="medical medical_review" href="/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis", section on 'Patients without accessible extrathoracic disease'</a>.)</p><p>Whether sarcoidosis can be diagnosed when there are cutaneous findings consistent with sarcoidosis but no other signs of sarcoidosis is controversial [<a href="#rid16">16</a>]. In 1999, a joint statement from three expert societies indicated that the detection of noncaseating granulomas in the skin was not sufficient to confirm a diagnosis of sarcoidosis in the absence of evidence for other organ involvement [<a href="#rid135">135</a>]. However, others, including ourselves, support the existence of isolated cutaneous sarcoidosis [<a href="#rid136">136</a>].</p><p class="headingAnchor" id="H1775135699"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>An examination of the skin is the first step towards confirming a diagnosis of cutaneous sarcoidosis. Although there are no physical features that confirm a diagnosis of cutaneous sarcoidosis, clinician familiarity with potential manifestations of sarcoidosis is helpful for identifying patients who may benefit from a skin biopsy to assess for sarcoidosis. (See <a class="local">'Specific lesions'</a> above.)</p><p>Additional examination techniques that can support clinical suspicion for sarcoidosis include diascopy and dermoscopy.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diascopy</strong> – Diascopy, a procedure that involves compressing a skin lesion with a clear glass microscope slide, is a simple method for detecting cutaneous granulomatous disorders on clinical examination. In granulomatous conditions, diascopy often reveals a subtle, brown-yellow or "apple jelly" color during lesion compression. This sign is most appreciable in individuals with light skin pigmentation. Diascopy is not a specific test for sarcoidosis, and other granulomatous disorders can exhibit similar findings.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dermoscopy</strong> – Dermatoscopic evaluation is also not a specific diagnostic technique for cutaneous sarcoidosis, as similar findings may occur in other granulomatous lesions. The typical findings include translucent, round or ovoid, yellowish or reddish-orange, focally or diffusely distributed globules. Common vascular features include linear vessels, branching vessels, or arborizing vessels; less common vascular findings are glomerular or dotted structures [<a href="#rid137">137</a>] and whitish, structureless areas on a yellow-orange background.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reflectance confocal microscopy</strong> – Although not typically performed in the clinical setting, reflectance confocal microscopic examination may demonstrate roundish structures, corresponding to granulomas with giant multinucleated cells inside characterized by a dark nuclei surrounded by a highly hyper-refractile cytoplasm [<a href="#rid138">138</a>]. These findings do not differentiate between sarcoidosis and other granulomatous lesions.</p><p></p><p class="headingAnchor" id="H2480640088"><span class="h2">Skin biopsy</span><span class="headingEndMark"> — </span>In lesions that are clinically suspicious for sarcoidosis, a skin biopsy should be performed. Ideally, biopsies should include the full thickness of the dermis and at least the superficial portion of the subcutaneous tissue; a punch biopsy or incisional biopsy is generally sufficient. (See  <a class="medical medical_review" href="/d/html/5577.html" rel="external">"Skin biopsy techniques", section on 'Punch biopsy'</a>.)</p><p>Although noncaseating granulomas with sparse peripheral lymphocytic infiltrates are characteristic of sarcoidosis, similar histopathologic features may be seen in other disorders, and not all lesions of sarcoidosis demonstrate classic findings [<a href="#rid139">139</a>]. (See <a class="local">'Histopathology'</a> above.)</p><p>Biopsy specimens should be examined under polarized light to evaluate for the presence of refractile material that could indicate granuloma formation secondary to a foreign body reaction. In addition, tissue staining for acid-fast bacilli and fungi, microbial cultures of fresh tissue, and tuberculin skin testing should be performed if clinical or histopathologic features suggest the possibility of mycobacterial or deep fungal infections [<a href="#rid23">23,96,140</a>].</p><p class="headingAnchor" id="H1174383"><span class="h2">Evaluation for systemic disease</span><span class="headingEndMark"> — </span>In the patient presenting with cutaneous lesions that are clinically and histopathologically consistent with sarcoidosis, the following work-up for systemic disease should be performed [<a href="#rid141">141-143</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Focused patient history and review of systems</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Complete physical examination</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Posterior and anterior chest radiography</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonary function tests including diffusing capacity studies (see  <a class="medical medical_review" href="/d/html/6969.html" rel="external">"Overview of pulmonary function testing in adults"</a> and  <a class="medical medical_review" href="/d/html/5735.html" rel="external">"Overview of pulmonary function testing in children"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Electrocardiogram</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ophthalmologic examination</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Laboratory studies (complete blood count [CBC], serum calcium, hepatic transaminases, alkaline phosphatase, blood urea nitrogen [BUN], serum creatinine, urinalysis)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10029" href="/d/drug information/10029.html" rel="external">Tuberculin skin test</a> or interferon-gamma release assay for latent tuberculosis (to assist with identifying patients who may have tuberculosis rather than sarcoidosis) (see  <a class="medical medical_review" href="/d/html/15352.html" rel="external">"Use of interferon-gamma release assays for diagnosis of tuberculosis infection (tuberculosis screening) in adults"</a> and  <a class="medical medical_review" href="/d/html/115049.html" rel="external">"Tuberculosis infection (latent tuberculosis) in adults: Approach to diagnosis (screening)"</a>)</p><p></p><p>Invasive diagnostic tests, such as intrathoracic lymph node biopsies, are also utilized for the recognition of extracutaneous sarcoidosis but are not necessary for all patients. Indications for invasive diagnostic testing are reviewed separately. (See  <a class="medical medical_review" href="/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis", section on 'Invasive diagnostic testing'</a>.)</p><p class="headingAnchor" id="H1174390"><span class="h2">Other tests</span><span class="headingEndMark"> — </span>Other tests that are <strong>not</strong> indicated for the diagnosis of sarcoidosis but have been used in the evaluation of sarcoidosis include angiotensin-converting enzyme (ACE) level; other serum markers of sarcoidosis; and historically, the intradermal (Kveim-Siltzbach) test. (See  <a class="medical medical_review" href="/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis", section on 'Proposed activity tests, including angiotensin converting enzyme (ACE) level'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>ACE level</strong> – Measurement of serum angiotensin-converting enzyme (ACE) level is sometimes considered in patients who present with signs or symptoms suggestive of sarcoidosis. However, ACE levels are nonspecific for the diagnosis of sarcoidosis [<a href="#rid7">7</a>]. ACE levels are sometimes used for following the response to treatment in patients with systemic sarcoidosis; the value of the test for this indication remains unclear.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other serologic studies</strong> – Other markers, such as serum lysozyme, neopterin, soluble interleukin (IL) 2 receptor, and osteopontin, that can be elevated in the presence of granulomatous disease are even less specific than ACE levels for the diagnosis of sarcoidosis and are unlikely to be elevated in patients in whom the disease burden is limited to the skin [<a href="#rid144">144</a>]. In a targeted evaluation of primers associated with sarcoidosis in ribonucleic acid (RNA) from paraffin-embedded sarcoidal tissue (most from lymph nodes), T-bet messenger ribonucleic acid (mRNA) expression was the only marker significantly greater in sarcoid granulomas than both suture granulomas and fungal granulomas [<a href="#rid145">145</a>]. Laboratory abnormalities, such as leukopenia, anemia, eosinophilia, and hypercalcemia, are rare in the absence of systemic disease.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Kveim-Siltzbach test</strong> – Historically, the Kveim-Siltzbach test was used in the diagnosis of sarcoidosis [<a href="#rid59">59</a>]. The test involves the injection of spleen extract from an individual with systemic sarcoidosis into the dermis of patients with signs or symptoms suggestive of sarcoidosis. The injection site is subsequently biopsied to assess for the formation of granulomas. In one series of 127 patients with cutaneous sarcoidosis, 38 percent had a positive Kveim test six weeks after injection [<a href="#rid59">59</a>].</p><p></p><p class="bulletIndent1">Due to poor standardization of the test, concern about transfer of viral infections, and unavailability of the substrate in many countries, the Kveim-Siltzbach test is rarely performed in the clinical setting.</p><p></p><p class="headingAnchor" id="H1869105560"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/116637.html" rel="external">"Society guideline links: Sarcoidosis"</a>.)</p><p class="headingAnchor" id="H62440086"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/85627.html" rel="external">"Patient education: Erythema nodosum (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H18191978"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Disease overview</strong> – Sarcoidosis is a granulomatous disease that can affect various organs, such as the lung, heart, neurologic system, gastrointestinal tract, skin, bone, and joints. The presence of noncaseating granulomas in organs and tissue is a classic feature. Cutaneous involvement is estimated to occur in approximately 25 percent of patients and has a wide variety of clinical manifestations. (See <a class="local">'Introduction'</a> above and  <a class="medical medical_review" href="/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis</strong> – The pathogenesis of cutaneous sarcoidosis is not well understood. A combination of genetic and environmental factors may contribute to an aberrant immune response and granuloma formation. (See <a class="local">'Pathogenesis'</a> above and  <a class="medical medical_review" href="/d/html/4365.html" rel="external">"Pathology and pathogenesis of sarcoidosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – The cutaneous manifestations of sarcoidosis may be divided into specific and nonspecific lesions. Specific lesions of sarcoidosis classically demonstrate noncaseating granulomas with sparse peripheral lymphocytic infiltrates on biopsy. Nonspecific lesions are cutaneous disorders that are associated with sarcoidosis but do not demonstrate these histopathologic features. (See <a class="local">'Classification'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Specific lesions</strong> – The morphology of specific cutaneous lesions of sarcoidosis varies widely. Examples of clinical manifestations include papules; nodules; plaques; and hypopigmented, atrophic, or ulcerative lesions  (<a class="graphic graphic_picture graphicRef73271 graphicRef53918 graphicRef59868 graphicRef52189 graphicRef69405 graphicRef78202 graphicRef51560 graphicRef62363 graphicRef74163 graphicRef70564" href="/d/graphic/73271.html" rel="external">picture 1A-J</a>). Several rare variants may closely resemble other cutaneous diseases. Presentations of sarcoidosis in particular sites have also been described, such as scar tissue, tattoos, scalp skin, genital skin, nail, and oral cavity. (See <a class="local">'Specific lesions'</a> above and <a class="local">'Rare variants'</a> above and <a class="local">'Special sites'</a> above.)</p><p></p><p class="bulletIndent2">Lupus pernio is a distinct variant of cutaneous sarcoidosis that presents with violaceous or erythematous papules, plaques, or nodules predominantly involving the central facial skin  (<a class="graphic graphic_picture graphicRef76184 graphicRef63312" href="/d/graphic/76184.html" rel="external">picture 4A-B</a>). The nasal alae are often affected. Patients with lupus pernio appear to have an increased risk for respiratory tract sarcoidosis. (See <a class="local">'Lupus pernio'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Nonspecific lesions</strong> – Erythema nodosum, a form of panniculitis, is the most common nonspecific manifestation of sarcoidosis. Patients usually present with inflammatory plaques or nodules on the lower legs. A skin biopsy is useful for distinguishing erythema nodosum from subcutaneous sarcoidosis. Examples of other nonspecific eruptions include calcinosis cutis, erythema multiforme, prurigo, Sweet syndrome, and nail clubbing. (See <a class="local">'Erythema nodosum'</a> above and <a class="local">'Nonspecific lesions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of cutaneous sarcoidosis involves a physical examination that identifies skin lesions that are morphologically compatible with sarcoidosis, a skin biopsy that demonstrates sarcoidal granulomas on histopathologic examination, and the exclusion of other disorders in the differential diagnosis.</p><p></p><p class="bulletIndent1">The differential diagnosis of cutaneous sarcoidosis is broad and includes multiple infectious and noninfectious disorders that may exhibit cutaneous granulomas. The specific clinical findings guide the differential diagnosis. Examples of disorders that are often in the differential diagnosis include deep fungal infections, tuberculosis, nontuberculous mycobacterial infections, and foreign body reactions. Special histopathologic stains and fresh tissue cultures can be helpful for identifying infection. Histopathologic examination under polarized light can aid with the detection of foreign bodies in the skin. (See <a class="local">'Histopathology'</a> above and <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation for systemic disease</strong> – Patients with cutaneous sarcoidosis should be evaluated for extracutaneous involvement. Testing should include a complete physical examination, chest radiograph, pulmonary function test, electrocardiogram, tuberculin skin testing, a urinalysis, and several blood studies. (See <a class="local">'Evaluation for systemic disease'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Hanno R, Needelman A, Eiferman RA, Callen JP. Cutaneous sarcoidal granulomas and the development of systemic sarcoidosis. Arch Dermatol 1981; 117:203.</a></li><li><a class="nounderline abstract_t">English JC 3rd, Patel PJ, Greer KE. Sarcoidosis. J Am Acad Dermatol 2001; 44:725.</a></li><li><a class="nounderline abstract_t">Samtsov AV. Cutaneous sarcoidosis. Int J Dermatol 1992; 31:385.</a></li><li><a class="nounderline abstract_t">Mangas C, Fernández-Figueras MT, Fité E, et al. Clinical spectrum and histological analysis of 32 cases of specific cutaneous sarcoidosis. J Cutan Pathol 2006; 33:772.</a></li><li><a class="nounderline abstract_t">Elgart MD. Skin manifestations of sarcoidosis. Cutis 1965; 1:283.</a></li><li><a class="nounderline abstract_t">Marcoval J, Mañá J, Rubio M. Specific cutaneous lesions in patients with systemic sarcoidosis: relationship to severity and chronicity of disease. Clin Exp Dermatol 2011; 36:739.</a></li><li><a class="nounderline abstract_t">Lodha S, Sanchez M, Prystowsky S. Sarcoidosis of the skin: a review for the pulmonologist. Chest 2009; 136:583.</a></li><li><a class="nounderline abstract_t">Sanchez M, Haimovic A, Prystowsky S. Sarcoidosis. Dermatol Clin 2015; 33:389.</a></li><li><a class="nounderline abstract_t">Yanardağ H, Pamuk ON, Karayel T. Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients. Respir Med 2003; 97:978.</a></li><li><a class="nounderline abstract_t">Ben Jennet S, Benmously R, Chaâbane S, et al. [Cutaneous sarcoidosis through a hospital series of 28 cases]. Tunis Med 2008; 86:447.</a></li><li class="breakAll">Lynch PJ, Sams WM Jr. Principles and Practice of Dermatology, Churchill Livingstone Inc, 1996.</li><li><a class="nounderline abstract_t">Elgart ML. Cutaneous sarcoidosis: definitions and types of lesions. Clin Dermatol 1986; 4:35.</a></li><li><a class="nounderline abstract_t">Arkema EV, Cozier YC. Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors. Curr Opin Pulm Med 2020; 26:527.</a></li><li><a class="nounderline abstract_t">Lundkvist A, Kullberg S, Arkema EV, et al. Differences in disease presentation between men and women with sarcoidosis: A cohort study. Respir Med 2022; 191:106688.</a></li><li><a class="nounderline abstract_t">James DG, Kendig EL Jr. Childhood sarcoidosis. Sarcoidosis 1988; 5:57.</a></li><li><a class="nounderline abstract_t">Ezeh N, Caplan A, Rosenbach M, Imadojemu S. Cutaneous Sarcoidosis. Dermatol Clin 2023; 41:455.</a></li><li><a class="nounderline abstract_t">Kassamali B, Villa-Ruiz C, Kus KJB, et al. Increased risk of systemic and cardiac sarcoidosis in Black patients with cutaneous sarcoidosis. J Am Acad Dermatol 2022; 86:1178.</a></li><li><a class="nounderline abstract_t">Zaba LC, Smith GP, Sanchez M, Prystowsky SD. Dendritic cells in the pathogenesis of sarcoidosis. Am J Respir Cell Mol Biol 2010; 42:32.</a></li><li><a class="nounderline abstract_t">Ali MM, Atwan AA, Gonzalez ML. Cutaneous sarcoidosis: updates in the pathogenesis. J Eur Acad Dermatol Venereol 2010; 24:747.</a></li><li><a class="nounderline abstract_t">Kim YC, Triffet MK, Gibson LE. Foreign bodies in sarcoidosis. Am J Dermatopathol 2000; 22:408.</a></li><li><a class="nounderline abstract_t">Derler AM, Eisendle K, Baltaci M, et al. High prevalence of 'Borrelia-like' organisms in skin biopsies of sarcoidosis patients from Western Austria. J Cutan Pathol 2009; 36:1262.</a></li><li><a class="nounderline abstract_t">Lassalle S, Selva E, Hofman V, et al. Sarcoid-like lesions associated with the immune restoration inflammatory syndrome in AIDS: absence of polymerase chain reaction detection of Mycobacterium tuberculosis in granulomas isolated by laser capture microdissection. Virchows Arch 2006; 449:689.</a></li><li><a class="nounderline abstract_t">Ball NJ, Kho GT, Martinka M. The histologic spectrum of cutaneous sarcoidosis: a study of twenty-eight cases. J Cutan Pathol 2004; 31:160.</a></li><li><a class="nounderline abstract_t">Marcoval J, Mañá J, Moreno A, et al. Foreign bodies in granulomatous cutaneous lesions of patients with systemic sarcoidosis. Arch Dermatol 2001; 137:427.</a></li><li><a class="nounderline abstract_t">Walsh NM, Hanly JG, Tremaine R, Murray S. Cutaneous sarcoidosis and foreign bodies. Am J Dermatopathol 1993; 15:203.</a></li><li><a class="nounderline abstract_t">Batres E, Klima M, Tschen J. Transepithelial elimination in cutaneous sarcoidosis. J Cutan Pathol 1982; 9:50.</a></li><li><a class="nounderline abstract_t">Callen JP. The presence of foreign bodies does not exclude the diagnosis of sarcoidosis. Arch Dermatol 2001; 137:485.</a></li><li><a class="nounderline abstract_t">Alexis JB. Sarcoidosis presenting as cutaneous hypopigmentation with repeatedly negative skin biopsies. Int J Dermatol 1994; 33:44.</a></li><li><a class="nounderline abstract_t">Shirodaria CC, Nicholson AG, Hansell DM, et al. Lesson of the month: Necrotizing sarcoid granulomatosis with skin involvement. Histopathology 2003; 43:91.</a></li><li><a class="nounderline abstract_t">Rosen Y, Moon S, Huang CT, et al. Granulomatous pulmonary angiitis in sarcoidosis. Arch Pathol Lab Med 1977; 101:170.</a></li><li><a class="nounderline abstract_t">Magro CM, Crowson AN, Regauer S. Granuloma annulare and necrobiosis lipoidica tissue reactions as a manifestation of systemic disease. Hum Pathol 1996; 27:50.</a></li><li><a class="nounderline abstract_t">Goldberg LJ, Goldberg N, Abrahams I, et al. Giant cell lichenoid dermatitis: a possible manifestation of sarcoidosis. J Cutan Pathol 1994; 21:47.</a></li><li><a class="nounderline abstract_t">Cardoso JC, Cravo M, Reis JP, Tellechea O. Cutaneous sarcoidosis: a histopathological study. J Eur Acad Dermatol Venereol 2009; 23:678.</a></li><li><a class="nounderline abstract_t">Esteves TC, Aparicio G, Ferrer B, Garcia-Patos V. Prognostic value of skin lesions in sarcoidosis: clinical and histopathological clues. Eur J Dermatol 2015; 25:556.</a></li><li><a class="nounderline abstract_t">Crouser ED, Maier LA, Wilson KC, et al. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 2020; 201:e26.</a></li><li><a class="nounderline abstract_t">Terushkin V, Stern BJ, Judson MA, et al. Neurosarcoidosis: presentations and management. Neurologist 2010; 16:2.</a></li><li><a class="nounderline abstract_t">Kim JS, Judson MA, Donnino R, et al. Cardiac sarcoidosis. Am Heart J 2009; 157:9.</a></li><li><a class="nounderline abstract_t">García-Colmenero L, Sánchez-Schmidt JM, Barranco C, Pujol RM. The natural history of cutaneous sarcoidosis. Clinical spectrum and histological analysis of 40 cases. Int J Dermatol 2019; 58:178.</a></li><li><a class="nounderline abstract_t">Byrne B, Goh A, Izham NF, et al. Systemic evaluation of cutaneous sarcoidosis: 15-year dermatology experience at University Hospital Limerick. Clin Exp Dermatol 2022; 47:850.</a></li><li><a class="nounderline abstract_t">Haimovic A, Sanchez M, Judson MA, Prystowsky S. Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease. J Am Acad Dermatol 2012; 66:699.e1.</a></li><li><a class="nounderline abstract_t">Hetherington S. Sarcoidosis in young children. Am J Dis Child 1982; 136:13.</a></li><li><a class="nounderline abstract_t">Milman N, Hoffmann AL. Childhood sarcoidosis: long-term follow-up. Eur Respir J 2008; 31:592.</a></li><li><a class="nounderline abstract_t">Katta R. Cutaneous sarcoidosis: a dermatologic masquerader. Am Fam Physician 2002; 65:1581.</a></li><li><a class="nounderline abstract_t">Mahajan VK, Sharma NL, Sharma RC, Sharma VC. Cutaneous sarcoidosis: clinical profile of 23 Indian patients. Indian J Dermatol Venereol Leprol 2007; 73:16.</a></li><li><a class="nounderline abstract_t">Labadie JG, Florek AG, VandenBoom T, et al. Micropapular Cutaneous Sarcoidosis Reviewed. Dermatology 2018; 234:220.</a></li><li><a class="nounderline abstract_t">Okamoto H, Horio T, Izumi T. Micropapular sarcoidosis simulating lichen nitidus. Dermatologica 1985; 170:253.</a></li><li><a class="nounderline abstract_t">Beacham BE, Schuldenfrei J, Julka SS. Sarcoidosis presenting with erythema multiforme-like cutaneous lesions. Cutis 1984; 33:461.</a></li><li><a class="nounderline abstract_t">Dumitrescu SM, Schwartz RA, Baredes S, et al. Mutilating facial sarcoidosis. Dermatology 1999; 199:265.</a></li><li><a class="nounderline abstract_t">Leonard AL. A case of sarcoidosis mimicking rhinophyma. J Drugs Dermatol 2003; 2:333.</a></li><li><a class="nounderline abstract_t">MAYOCK RL, BERTRAND P, MORRISON CE, SCOTT JH. MANIFESTATIONS OF SARCOIDOSIS. ANALYSIS OF 145 PATIENTS, WITH A REVIEW OF NINE SERIES SELECTED FROM THE LITERATURE. Am J Med 1963; 35:67.</a></li><li><a class="nounderline abstract_t">Vainsencher D, Winkelmann RK. Subcutaneous sarcoidosis. Arch Dermatol 1984; 120:1028.</a></li><li><a class="nounderline abstract_t">Rodriguez-Gomez M, Fernandez-Sueiro JL, Willisch A, et al. Multifocal dactylitis as the sole clinical expression of sarcoidosis. J Rheumatol 2000; 27:245.</a></li><li><a class="nounderline abstract_t">Ahmed I, Harshad SR. Subcutaneous sarcoidosis: is it a specific subset of cutaneous sarcoidosis frequently associated with systemic disease? J Am Acad Dermatol 2006; 54:55.</a></li><li><a class="nounderline abstract_t">Jacyk WK. Cutaneous sarcoidosis in black South Africans. Int J Dermatol 1999; 38:841.</a></li><li><a class="nounderline abstract_t">Spiteri MA, Matthey F, Gordon T, et al. Lupus pernio: a clinico-radiological study of thirty-five cases. Br J Dermatol 1985; 112:315.</a></li><li><a class="nounderline abstract_t">Young RJ 3rd, Gilson RT, Yanase D, Elston DM. Cutaneous sarcoidosis. Int J Dermatol 2001; 40:249.</a></li><li><a class="nounderline abstract_t">Aubart FC, Ouayoun M, Brauner M, et al. Sinonasal involvement in sarcoidosis: a case-control study of 20 patients. Medicine (Baltimore) 2006; 85:365.</a></li><li><a class="nounderline abstract_t">Jorizzo JL, Koufman JA, Thompson JN, et al. Sarcoidosis of the upper respiratory tract in patients with nasal rim lesions: a pilot study. J Am Acad Dermatol 1990; 22:439.</a></li><li><a class="nounderline abstract_t">Veien NK, Stahl D, Brodthagen H. Cutaneous sarcoidosis in Caucasians. J Am Acad Dermatol 1987; 16:534.</a></li><li><a class="nounderline abstract_t">Fernandez-Faith E, McDonnell J. Cutaneous sarcoidosis: differential diagnosis. Clin Dermatol 2007; 25:276.</a></li><li class="breakAll">Redissi A, Penmetsa GK, Litaiem N. Lupus pernio. In: StatPearls, StatPearls Publishing, Treasure Island (FL) 2023.</li><li><a class="nounderline abstract_t">Terunuma A, Watabe A, Kato T, Tagami H. Coexistence of vitiligo and sarcoidosis in a patient with circulating autoantibodies. Int J Dermatol 2000; 39:551.</a></li><li><a class="nounderline abstract_t">Sivasaththivel M, Lee S, Gupta S. A Case of hypopigmented sarcoidosis masquerading as Vitiligo in a Caucasian individual. Australas J Dermatol 2022; 63:124.</a></li><li><a class="nounderline abstract_t">Albertini JG, Tyler W, Miller OF 3rd. Ulcerative sarcoidosis. Case report and review of the literature. Arch Dermatol 1997; 133:215.</a></li><li><a class="nounderline abstract_t">Yoo SS, Mimouni D, Nikolskaia OV, et al. Clinicopathologic features of ulcerative-atrophic sarcoidosis. Int J Dermatol 2004; 43:108.</a></li><li><a class="nounderline abstract_t">Burov EA, Kantor GR, Isaac M. Morpheaform sarcoidosis: report of three cases. J Am Acad Dermatol 1998; 39:345.</a></li><li><a class="nounderline abstract_t">Hess SP, Agudelo CA, White WL, Jorizzo JL. Ichthyosiform and morpheaform sarcoidosis. Clin Exp Rheumatol 1990; 8:171.</a></li><li><a class="nounderline abstract_t">Huang CL, Mutasim DF. Sarcoidosis mimicking lipodermatosclerosis. Cutis 2005; 75:322.</a></li><li><a class="nounderline abstract_t">Arias-Santiago S, Fernández-Pugnaire MA, Aneiros-Fernández J, et al. Recurrent telangiectasias on the cheek: angiolupoid sarcoidosis. Am J Med 2010; 123:e7.</a></li><li><a class="nounderline abstract_t">Wanat KA, Schaffer A, Richardson V, et al. Sarcoidosis and psoriasis: a case series and review of the literature exploring co-incidence vs coincidence. JAMA Dermatol 2013; 149:848.</a></li><li><a class="nounderline abstract_t">Glass LA, Apisarnthanarax P. Verrucous sarcoidosis simulating hypertrophic lichen planus. Int J Dermatol 1989; 28:539.</a></li><li><a class="nounderline abstract_t">Ko R, Tanaka M, Murata T, Nishikawa T. Papular fixed drug eruption mimicking folliculitis due to acetominophen. Clin Exp Dermatol 2000; 25:96.</a></li><li><a class="nounderline abstract_t">Nishizawa A, Igawa K, Teraki H, Yokozeki H. Diffuse disseminated lichenoid-type cutaneous sarcoidosis mimicking erythroderma. Int J Dermatol 2014; 53:e369.</a></li><li><a class="nounderline abstract_t">Chen HW, Vandergriff T. Ichthyosiform sarcoidosis: Report of a case and comprehensive review of the literature. Int J Dermatol 2022; 61:390.</a></li><li><a class="nounderline abstract_t">Cather JC, Cohen PR. Ichthyosiform sarcoidosis. J Am Acad Dermatol 1999; 40:862.</a></li><li><a class="nounderline abstract_t">Feind-Koopmans AG, Lucker GP, van de Kerkhof PC. Acquired ichthyosiform erythroderma and sarcoidosis. J Am Acad Dermatol 1996; 35:826.</a></li><li><a class="nounderline abstract_t">ZHANG H, MA HJ, LIU W, YUAN XY. Sarcoidosis characterized as acquired ichthyosiform erythroderma. Eur J Dermatol 2009; 19:516.</a></li><li><a class="nounderline abstract_t">Greer KE, Harman LE Jr, Kayne AL. Unusual cutaneous manifestations of sarcoidosis. South Med J 1977; 70:666.</a></li><li><a class="nounderline abstract_t">Wirth FA, Gould WM, Kauffman CL. Erythroderma in a patient with arthralgias, uveitis, and dyspnea. Arch Dermatol 1999; 135:1411, 1414.</a></li><li><a class="nounderline abstract_t">Bazex J, Dupin P, Giordano F. [Cutaneous and visceral sarcoidosis. Apropos of an exceptional form]. Ann Dermatol Venereol 1987; 114:685.</a></li><li><a class="nounderline abstract_t">Morrison JG. Sarcoidosis in a child, presenting as an erythroderma with keratotic spines and palmar pits. Br J Dermatol 1976; 95:93.</a></li><li><a class="nounderline abstract_t">Yoon CH, Lee CW. Case 6. Erythrodermic form of cutaneous sarcoidosis. Clin Exp Dermatol 2003; 28:575.</a></li><li><a class="nounderline abstract_t">Hagari Y, Kambe N, Shimao S, et al. Cutaneous sarcoidosis showing multiple papular eruptions with keratotic plugs. J Dermatol 1989; 16:321.</a></li><li><a class="nounderline abstract_t">Ismail A, Beckum K, McKay K. Transepithelial elimination in sarcoidosis: a frequent finding. J Cutan Pathol 2014; 41:22.</a></li><li><a class="nounderline abstract_t">Truchot F, Skowron F, Grande S, et al. [Photo-induced sarcoidosis]. Ann Dermatol Venereol 2003; 130:40.</a></li><li><a class="nounderline abstract_t">Macdonald J, Southgate HJ. Lessons to be learned: a case study approach. Sunshine-induced hypercalcaemia? J R Soc Promot Health 2002; 122:194.</a></li><li><a class="nounderline abstract_t">MOSER HS, SOLOWEY CM, LEIDER M. An unusual form of cutaneous sarcoidosis. N Y State J Med 1962; 62:1859.</a></li><li><a class="nounderline abstract_t">Hayakawa J, Mizukawa Y, Kurata M, Shiohara T. A syringotropic variant of cutaneous sarcoidosis: presentation of 3 cases exhibiting defective sweating responses. J Am Acad Dermatol 2013; 68:1016.</a></li><li><a class="nounderline abstract_t">Nishida M, Namiki T, Sone Y, et al. Acquired anhidrosis associated with systemic sarcoidosis: quantification of nerve fibres around eccrine glands by confocal microscopy. Br J Dermatol 2018; 178:e59.</a></li><li><a class="nounderline abstract_t">Norton SA, Chesser RS, Fitzpatrick JE. Scar sarcoidosis in pseudofolliculitis barbae. Mil Med 1991; 156:369.</a></li><li><a class="nounderline abstract_t">Cecchi R, Giomi A. Scar sarcoidosis following herpes zoster. J Eur Acad Dermatol Venereol 1999; 12:280.</a></li><li><a class="nounderline abstract_t">Kormeili T, Neel V, Moy RL. Cutaneous sarcoidosis at sites of previous laser surgery. Cutis 2004; 73:53.</a></li><li><a class="nounderline abstract_t">Payne CM, Thomas RH, Black MM. From silica granuloma to scar sarcoidosis. Clin Exp Dermatol 1983; 8:171.</a></li><li><a class="nounderline abstract_t">Buss G, Cattin V, Spring P, et al. Two cases of interferon-alpha-induced sarcoidosis Koebnerized along venous drainage lines: new pathogenic insights and review of the literature of interferon-induced sarcoidosis. Dermatology 2013; 226:289.</a></li><li><a class="nounderline abstract_t">JAMES DG. Dermatological aspects of sarcoidosis. Q J Med 1959; 28:108.</a></li><li><a class="nounderline abstract_t">Chudomirova K, Velichkova L, Anavi B, Arnaudova M. Recurrent sarcoidosis in skin scars accompanying systemic sarcoidosis. J Eur Acad Dermatol Venereol 2003; 17:360.</a></li><li><a class="nounderline abstract_t">Sorabjee JS, Garje R. Reactivation of old scars: inevitably sarcoid. Postgrad Med J 2005; 81:60.</a></li><li><a class="nounderline abstract_t">Antonovich DD, Callen JP. Development of sarcoidosis in cosmetic tattoos. Arch Dermatol 2005; 141:869.</a></li><li><a class="nounderline abstract_t">Rapp SE. An unusual cause of hair loss. Arch Dermatol 2002; 138:259.</a></li><li><a class="nounderline abstract_t">Katta R, Nelson B, Chen D, Roenigk H. Sarcoidosis of the scalp: a case series and review of the literature. J Am Acad Dermatol 2000; 42:690.</a></li><li><a class="nounderline abstract_t">Knight L, Ngwanya M. Sarcoidosis of the scalp: the largest single-institutional case series. Int J Dermatol 2019; 58:e149.</a></li><li><a class="nounderline abstract_t">Henderson CL, Lafleur L, Sontheimer RD. Sarcoidal alopecia as a mimic of discoid lupus erythematosus. J Am Acad Dermatol 2008; 59:143.</a></li><li><a class="nounderline abstract_t">Torres F, Tosti A, Misciali C, Lorenzi S. Trichoscopy as a clue to the diagnosis of scalp sarcoidosis. Int J Dermatol 2011; 50:358.</a></li><li><a class="nounderline abstract_t">Mann RJ, Allen BR. Nail dystrophy due to sarcoidosis. Br J Dermatol 1981; 105:599.</a></li><li><a class="nounderline abstract_t">Davies MG, McGavin CR. Onycholysis in sarcoidosis--a previously undescribed association. Br J Dermatol 1996; 135:340.</a></li><li><a class="nounderline abstract_t">Fujii K, Kanno Y, Ohgo N. Subungual hyperkeratosis due to sarcoidosis. Int J Dermatol 1997; 36:125.</a></li><li><a class="nounderline abstract_t">Kalb RE, Grossman ME. Pterygium formation due to sarcoidosis. Arch Dermatol 1985; 121:276.</a></li><li><a class="nounderline abstract_t">Aranegui B, Garcia-Cruz A, de la Torre C, González-Valladares MG. Trachyonychia and sarcoidosis. J Am Acad Dermatol 2010; 63:159.</a></li><li><a class="nounderline abstract_t">Losada-Campa A, De la Torre-Fraga C, Gomez de Liaño A, Cruces-Prado MJ. Histopathology of nail sarcoidosis. Acta Derm Venereol 1995; 75:404.</a></li><li><a class="nounderline abstract_t">Cox NH, Gawkrodger DJ. Nail dystrophy in chronic sarcoidosis. Br J Dermatol 1988; 118:697.</a></li><li><a class="nounderline abstract_t">Santoro F, Sloan SB. Nail dystrophy and bony involvement in chronic sarcoidosis. J Am Acad Dermatol 2009; 60:1050.</a></li><li><a class="nounderline abstract_t">Ezughah FI, Ghaly AF, Evans A, Green CM. Vulval sarcoid: a systemic presentation of sarcoidosis. J Obstet Gynaecol 2005; 25:730.</a></li><li><a class="nounderline abstract_t">Tatnall FM, Barnes HM, Sarkany I. Sarcoidosis of the vulva. Clin Exp Dermatol 1985; 10:384.</a></li><li><a class="nounderline abstract_t">de Oliveira Neto MP. [Sarcoidosis with vulvar lesions]. Rev Bras Med 1972; 29:134.</a></li><li><a class="nounderline abstract_t">Wei H, Friedman KA, Rudikoff D. Multiple indurated papules on penis and scrotum. J Cutan Med Surg 2000; 4:202.</a></li><li><a class="nounderline abstract_t">Mahmood N, Afzal N, Joyce A. Sarcoidosis of the penis. Br J Urol 1997; 80:155.</a></li><li><a class="nounderline abstract_t">Rubinstein I, Baum GL, Hiss Y. Sarcoidosis of the penis: report of a case. J Urol 1986; 135:1016.</a></li><li><a class="nounderline abstract_t">Vahid B, Weibel S, Nguyen C. Scrotal swelling and sarcoidosis. Am J Med 2006; 119:e3.</a></li><li><a class="nounderline abstract_t">HAUSFELD KF. Primary sarcoidosis of the scrotum: case report. J Urol 1961; 86:269.</a></li><li><a class="nounderline abstract_t">Suresh L, Radfar L. Oral sarcoidosis: a review of literature. Oral Dis 2005; 11:138.</a></li><li><a class="nounderline abstract_t">Blinder D, Yahatom R, Taicher S. Oral manifestations of sarcoidosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83:458.</a></li><li><a class="nounderline abstract_t">Jackowski J, Dragisic D, Arnold G, Dirschka T. Primary oral sarcoidosis preceding Lofgren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100:183.</a></li><li><a class="nounderline abstract_t">Kowalczyk JP, Ricotti CA, de Araujo T, et al. "Strawberry gums" in sarcoidosis. J Am Acad Dermatol 2008; 59:S118.</a></li><li><a class="nounderline abstract_t">García-Porrúa C, González-Gay MA, Vázquez-Caruncho M, et al. Erythema nodosum: etiologic and predictive factors in a defined population. Arthritis Rheum 2000; 43:584.</a></li><li><a class="nounderline abstract_t">Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med 1983; 52:525.</a></li><li><a class="nounderline abstract_t">Milman N, Selroos O. Pulmonary sarcoidosis in the Nordic countries 1950-1982. II. Course and prognosis. Sarcoidosis 1990; 7:113.</a></li><li><a class="nounderline abstract_t">Grunewald J, Eklund A. Sex-specific manifestations of Löfgren's syndrome. Am J Respir Crit Care Med 2007; 175:40.</a></li><li><a class="nounderline abstract_t">Mañá J, Gómez-Vaquero C, Montero A, et al. Löfgren's syndrome revisited: a study of 186 patients. Am J Med 1999; 107:240.</a></li><li><a class="nounderline abstract_t">Grunewald J, Eklund A. Löfgren's syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med 2009; 179:307.</a></li><li><a class="nounderline abstract_t">Okamoto H, Mizuno K, Imamura S, et al. Erythema nodosum-like eruption in sarcoidosis. Clin Exp Dermatol 1994; 19:507.</a></li><li><a class="nounderline abstract_t">Löfgren S. Erythema nodosum: study on etiology and pathogenesis in 185 adult cases. Acta Med Scand 1946; suppl 174.</a></li><li><a class="nounderline abstract_t">Marie I, Lecomte F, Levesque H, et al. Löfgren's syndrome as the first manifestation of acute infection due to Chlamydia pneumoniae: a prospective study. Clin Infect Dis 1999; 28:691.</a></li><li><a class="nounderline abstract_t">Scofield-Kaplan SM, Patel SY, Mueller A, et al. Foreign-Body Granulomata Caused by Injected Permanent Filler Masquerading as Cutaneous Sarcoidosis. Ophthalmic Plast Reconstr Surg 2019; 35:e82.</a></li><li><a class="nounderline abstract_t">Cohen Aubart F, Lhote R, Amoura A, et al. Drug-induced sarcoidosis: an overview of the WHO pharmacovigilance database. J Intern Med 2020; 288:356.</a></li><li><a class="nounderline abstract_t">Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160:736.</a></li><li><a class="nounderline abstract_t">Wanat KA, Rosenbach M. A practical approach to cutaneous sarcoidosis. Am J Clin Dermatol 2014; 15:283.</a></li><li><a class="nounderline abstract_t">Errichetti E, Stinco G. Dermatoscopy of Granulomatous Disorders. Dermatol Clin 2018; 36:369.</a></li><li><a class="nounderline abstract_t">Segurado-Miravalles G, Fernández-Nieto D, Suárez-Valle A, et al. Reflectance confocal microscopy of cutaneous sarcoidosis. Skin Res Technol 2021; 27:980.</a></li><li><a class="nounderline abstract_t">Miida H, Ito M. Tuberculoid granulomas in cutaneous sarcoidosis: a study of 49 cases. J Cutan Pathol 2010; 37:504.</a></li><li><a class="nounderline abstract_t">Moss J, Zic J, Drake W. Mycobacterial infection masquerading as cutaneous sarcoidosis. Clin Exp Dermatol 2009; 34:e199.</a></li><li><a class="nounderline abstract_t">Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J 1999; 14:735.</a></li><li><a class="nounderline abstract_t">Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997; 336:1224.</a></li><li><a class="nounderline abstract_t">Haimovic A, Sanchez M, Judson MA, Prystowsky S. Sarcoidosis: a comprehensive review and update for the dermatologist: part II. Extracutaneous disease. J Am Acad Dermatol 2012; 66:719.e1.</a></li><li><a class="nounderline abstract_t">Müller-Quernheim J. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J 1998; 12:716.</a></li><li><a class="nounderline abstract_t">Christophi GP, Caza T, Curtiss C, et al. Gene expression profiles in granuloma tissue reveal novel diagnostic markers in sarcoidosis. Exp Mol Pathol 2014; 96:393.</a></li></ol></div><div id="topicVersionRevision">Topic 13762 Version 18.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7212741" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Cutaneous sarcoidal granulomas and the development of systemic sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11312418" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1512087" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Cutaneous sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17177936" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Clinical spectrum and histological analysis of 32 cases of specific cutaneous sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Skin manifestations of sarcoidosis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21790725" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Specific cutaneous lesions in patients with systemic sarcoidosis: relationship to severity and chronicity of disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19666758" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Sarcoidosis of the skin: a review for the pulmonologist.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26143421" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12924527" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19469298" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : [Cutaneous sarcoidosis through a hospital series of 28 cases].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19469298" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : [Cutaneous sarcoidosis through a hospital series of 28 cases].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3542172" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Cutaneous sarcoidosis: definitions and types of lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32701677" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34839065" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Differences in disease presentation between men and women with sarcoidosis: A cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3381020" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Childhood sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37236714" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Cutaneous Sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33940102" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Increased risk of systemic and cardiac sarcoidosis in Black patients with cutaneous sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19372243" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Dendritic cells in the pathogenesis of sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20015176" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Cutaneous sarcoidosis: updates in the pathogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11048975" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Foreign bodies in sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19469874" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : High prevalence of 'Borrelia-like' organisms in skin biopsies of sarcoidosis patients from Western Austria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17043810" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Sarcoid-like lesions associated with the immune restoration inflammatory syndrome in AIDS: absence of polymerase chain reaction detection of Mycobacterium tuberculosis in granulomas isolated by laser capture microdissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14690461" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : The histologic spectrum of cutaneous sarcoidosis: a study of twenty-eight cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11295921" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Foreign bodies in granulomatous cutaneous lesions of patients with systemic sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8517493" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Cutaneous sarcoidosis and foreign bodies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7069023" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Transepithelial elimination in cutaneous sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11295930" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The presence of foreign bodies does not exclude the diagnosis of sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8112940" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Sarcoidosis presenting as cutaneous hypopigmentation with repeatedly negative skin biopsies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12823717" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Lesson of the month: Necrotizing sarcoid granulomatosis with skin involvement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/576782" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Granulomatous pulmonary angiitis in sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8543311" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Granuloma annulare and necrobiosis lipoidica tissue reactions as a manifestation of systemic disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8188933" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Giant cell lichenoid dermatitis: a possible manifestation of sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19298487" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Cutaneous sarcoidosis: a histopathological study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26553412" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Prognostic value of skin lesions in sarcoidosis: clinical and histopathological clues.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32293205" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20065791" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Neurosarcoidosis: presentations and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19081391" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Cardiac sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30306543" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The natural history of cutaneous sarcoidosis. Clinical spectrum and histological analysis of 40 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35020955" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Systemic evaluation of cutaneous sarcoidosis: 15-year dermatology experience at University Hospital Limerick.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22507585" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7055102" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Sarcoidosis in young children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18057063" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Childhood sarcoidosis: long-term follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11989634" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Cutaneous sarcoidosis: a dermatologic masquerader.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17314441" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Cutaneous sarcoidosis: clinical profile of 23 Indian patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30278434" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Micropapular Cutaneous Sarcoidosis Reviewed.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4007221" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Micropapular sarcoidosis simulating lichen nitidus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6478870" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Sarcoidosis presenting with erythema multiforme-like cutaneous lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10592412" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Mutilating facial sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12848119" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : A case of sarcoidosis mimicking rhinophyma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14046006" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : MANIFESTATIONS OF SARCOIDOSIS. ANALYSIS OF 145 PATIENTS, WITH A REVIEW OF NINE SERIES SELECTED FROM THE LITERATURE.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6465908" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Subcutaneous sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10648047" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Multifocal dactylitis as the sole clinical expression of sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16384755" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Subcutaneous sarcoidosis: is it a specific subset of cutaneous sarcoidosis frequently associated with systemic disease?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10583617" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Cutaneous sarcoidosis in black South Africans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2983750" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Lupus pernio: a clinico-radiological study of thirty-five cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11454079" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Cutaneous sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17108780" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Sinonasal involvement in sarcoidosis: a case-control study of 20 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2312830" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Sarcoidosis of the upper respiratory tract in patients with nasal rim lesions: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3819097" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Cutaneous sarcoidosis in Caucasians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17560305" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Cutaneous sarcoidosis: differential diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17560305" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Cutaneous sarcoidosis: differential diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10940124" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Coexistence of vitiligo and sarcoidosis in a patient with circulating autoantibodies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34398468" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : A Case of hypopigmented sarcoidosis masquerading as Vitiligo in a Caucasian individual.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9041836" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Ulcerative sarcoidosis. Case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15125500" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Clinicopathologic features of ulcerative-atrophic sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9703149" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Morpheaform sarcoidosis: report of three cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2338012" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Ichthyosiform and morpheaform sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16047869" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Sarcoidosis mimicking lipodermatosclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20102979" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Recurrent telangiectasias on the cheek: angiolupoid sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23783749" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Sarcoidosis and psoriasis: a case series and review of the literature exploring co-incidence vs coincidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2583895" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Verrucous sarcoidosis simulating hypertrophic lichen planus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10819605" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Papular fixed drug eruption mimicking folliculitis due to acetominophen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25041485" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Diffuse disseminated lichenoid-type cutaneous sarcoidosis mimicking erythroderma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33929723" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Ichthyosiform sarcoidosis: Report of a case and comprehensive review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10321636" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Ichthyosiform sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8912596" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Acquired ichthyosiform erythroderma and sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19527990" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Sarcoidosis characterized as acquired ichthyosiform erythroderma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/141730" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Unusual cutaneous manifestations of sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10566847" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Erythroderma in a patient with arthralgias, uveitis, and dyspnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3631844" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : [Cutaneous and visceral sarcoidosis. Apropos of an exceptional form].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/133705" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Sarcoidosis in a child, presenting as an erythroderma with keratotic spines and palmar pits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12950367" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Case 6. Erythrodermic form of cutaneous sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2600269" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Cutaneous sarcoidosis showing multiple papular eruptions with keratotic plugs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24151900" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Transepithelial elimination in sarcoidosis: a frequent finding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12605156" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : [Photo-induced sarcoidosis].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12391835" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Lessons to be learned: a case study approach. Sunshine-induced hypercalcaemia?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14476452" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : An unusual form of cutaneous sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23374232" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : A syringotropic variant of cutaneous sarcoidosis: presentation of 3 cases exhibiting defective sweating responses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28796884" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Acquired anhidrosis associated with systemic sarcoidosis: quantification of nerve fibres around eccrine glands by confocal microscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1922852" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Scar sarcoidosis in pseudofolliculitis barbae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10461661" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Scar sarcoidosis following herpes zoster.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14964632" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Cutaneous sarcoidosis at sites of previous laser surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6303651" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : From silica granuloma to scar sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23886768" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Two cases of interferon-alpha-induced sarcoidosis Koebnerized along venous drainage lines: new pathogenic insights and review of the literature of interferon-induced sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13634348" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Dermatological aspects of sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12702092" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Recurrent sarcoidosis in skin scars accompanying systemic sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15640432" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Reactivation of old scars: inevitably sarcoid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16027303" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Development of sarcoidosis in cosmetic tattoos.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11843650" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : An unusual cause of hair loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10727323" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Sarcoidosis of the scalp: a case series and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31115900" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Sarcoidosis of the scalp: the largest single-institutional case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18378353" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Sarcoidal alopecia as a mimic of discoid lupus erythematosus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21342171" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Trichoscopy as a clue to the diagnosis of scalp sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7295575" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Nail dystrophy due to sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8881699" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Onycholysis in sarcoidosis--a previously undescribed association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9109010" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Subungual hyperkeratosis due to sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3977350" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Pterygium formation due to sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20542178" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Trachyonychia and sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8615065" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Histopathology of nail sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3395565" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Nail dystrophy in chronic sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19467377" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Nail dystrophy and bony involvement in chronic sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16263562" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Vulval sarcoid: a systemic presentation of sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4042410" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Sarcoidosis of the vulva.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5033153" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : [Sarcoidosis with vulvar lesions].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11231193" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Multiple indurated papules on penis and scrotum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9240203" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Sarcoidosis of the penis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3959228" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Sarcoidosis of the penis: report of a case.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17071149" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Scrotal swelling and sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13712330" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Primary sarcoidosis of the scrotum: case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15888103" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Oral sarcoidosis: a review of literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9127377" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Oral manifestations of sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16037776" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Primary oral sarcoidosis preceding Lofgren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19119120" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : "Strawberry gums" in sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10728752" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Erythema nodosum: etiologic and predictive factors in a defined population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6657915" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2255786" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Pulmonary sarcoidosis in the Nordic countries 1950-1982. II. Course and prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17023727" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Sex-specific manifestations of Löfgren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10492317" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Löfgren's syndrome revisited: a study of 186 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18996998" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Löfgren's syndrome: human leukocyte antigen strongly influences the disease course.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7889676" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Erythema nodosum-like eruption in sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Erythema nodosum: study on etiology and pathogenesis in 185 adult cases</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10194106" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Löfgren's syndrome as the first manifestation of acute infection due to Chlamydia pneumoniae: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30921058" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Foreign-Body Granulomata Caused by Injected Permanent Filler Masquerading as Cutaneous Sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31612562" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Drug-induced sarcoidosis: an overview of the WHO pharmacovigilance database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10430755" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24820822" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : A practical approach to cutaneous sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30201146" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Dermatoscopy of Granulomatous Disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34532889" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Reflectance confocal microscopy of cutaneous sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19615012" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Tuberculoid granulomas in cutaneous sarcoidosis: a study of 49 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19040506" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Mycobacterial infection masquerading as cutaneous sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10573213" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9110911" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22507586" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Sarcoidosis: a comprehensive review and update for the dermatologist: part II. Extracutaneous disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9762805" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Sarcoidosis: immunopathogenetic concepts and their clinical application.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24768588" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Gene expression profiles in granuloma tissue reveal novel diagnostic markers in sarcoidosis.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
